98%
921
2 minutes
20
Objective: To investigate the association between using screen in the dark-a predominant source of LAN-and depressive symptoms in Chinese adolescents.
Methods: This study utilized a sample of 3659 adolescents (51.87% boy, mean age 14.41 ± 1.55 years) from the 2020-2022 Surveillance of Students' Common Diseases and Health Influencing Factors in Shanghai, China. Baseline screen usage was collected by self-reported questionnaire. Depressive symptoms at baseline, 1- and 2-year follow-up were assessed using the Center for Epidemiology Scale. Generalized estimating equations were used to evaluate the association of using screen in the dark with depressive symptoms.
Results: The prevalence of depressive symptoms and severe depressive symptoms in this study was 23.59% and 5.25% respectively at baseline. 15.76% adolescents who had depressive symptoms in 2020 aggravated to severe depressive symptoms in 2021 or 2022. 12.38% of the participants reported using screen in the dark. Using screen in the dark was associated with higher likelihood of depressive symptoms ( = 1.89, 95%: 1.67, 2.15) and severe depressive symptoms ( = 1.89, 95%: 1.54, 2.31). The adverse effect of using screen in the dark and screen time > 2 hours/day on depressive symptoms was slightly higher than only screen time > 2 hours/day ( = 1.24, 95%: 1.12, 1.37) or only using screen in the dark ( = 2.15, 95%: 1.73, 2.67). Additionally, those who using screen in the dark combination with screen time > 2 hours/day or insufficient sleep have the highest likelihood of depressive symptoms.
Conclusions: Screen use in dark environments independently related to depressive symptoms in adolescents, with compounded associations from excessive screen time and sleep deprivation. These findings underscore the need for public health interventions targeting nighttime digital behaviors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405338 | PMC |
http://dx.doi.org/10.3389/fpsyt.2025.1618965 | DOI Listing |
J Neural Transm (Vienna)
September 2025
Parkinson's Foundation Centre of Excellence, King's College Hospital, Denmark Hill, London, SE5 9RS, UK.
Parkinson's disease patients are at increased risk of road traffic and car accidents and those with excessive daytime sleepiness are specially susceptible. Abnormal scores on the Epworth Sleepiness Scale predicts risk for driving-related somnolence which may cause road traffic accidents in driving patients as many such patients declare dozing of while in a car. Our study estimates that over 40% of patients with daytime somnolence have risks of dozing off in a car.
View Article and Find Full Text PDFJ Neural Transm (Vienna)
September 2025
Sárospatak College, Sztárai Institute, University of Tokaj, Eötvöst str. 7, Sárospatak, 3944, Hungary.
Generalized Anxiety Disorder (GAD) is characterized by excessive worry and physical symptoms of prolonged anxiety. Patients with subclinical GAD-states (sub-GAD) do not fulfill the diagnostic criteria of GAD, but they often show a disease burden similar to GAD, and the subclinical state may turn into a full syndrome. Neuroinflammation may contribute to changes in brain structures in sub-GAD, but direct evidence remains lacking.
View Article and Find Full Text PDFMol Psychiatry
September 2025
National Center for PTSD, Behavioral Science Division, VA Boston Healthcare System, Boston, MA, 02130, USA.
Glial fibrillary acidic protein (GFAP) is an astrocytic marker that can be assessed in blood using single molecule array technology. Recent studies suggest that individuals with posttraumatic stress disorder (PTSD) have suppressed circulating levels of this CNS biomarker. This study examined the hypothesis that PTSD and plasma GFAP levels share common genetic and epigenetic pathways.
View Article and Find Full Text PDFOccup Environ Med
September 2025
National Institute of Occupational Health, Oslo, Norway.
This systematic review examined the impact of unemployment and re-employment on mental health problems (depression, anxiety and psychological distress) among working-age adults. We searched MEDLINE, Embase, APA PsycINFO and Web of Science (January 2012-March 2024) and included studies from a prior meta-analysis (1990-2012). Risk of bias was assessed using the Newcastle-Ottawa Scale.
View Article and Find Full Text PDFEur Urol Focus
September 2025
Department of Urology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Background And Objective: While whole-gland therapies for localized prostate cancer (PCa) offer excellent oncological outcomes, these can impact patients' quality of life (QoL) through serious side effects. Focal therapy using high-intensity focused ultrasound (HIFU) has emerged as a less invasive alternative to preserve QoL. However, data on the psychological impact of HIFU remain rare.
View Article and Find Full Text PDF